Governor announces $30M investment in Massachusetts life sciences to create 1500 jobs

Governor Maura Healey announced a significant investment in Massachusetts' life sciences sector during a recent government meeting, pledging $30 million to 33 companies that are set to create over 1,500 new jobs across the state. This initiative is part of the Massachusetts Life Sciences Initiative, which has been extended for another decade under the recently passed MASL LEADS Act.

The funding will directly benefit companies such as Lila Sciences, which will add 100 jobs, and Vertex Pharmaceuticals in Boston, which is expected to create 300 jobs. Other companies receiving support include Anilum in Norton, Insulet in Acton, and Cipla in Fall River, among others. This investment not only aims to bolster the local economy but also positions Massachusetts as a leader in the life sciences field, especially in light of recent federal funding cuts to research institutions.

Governor Healey emphasized the importance of nurturing the life sciences ecosystem in Massachusetts, highlighting the state's robust infrastructure, talented workforce, and commitment to innovation. She noted that Massachusetts is home to 95% of the world's largest biotech companies and leads the nation in venture capital and NIH funding per capita.

As the state prepares to host the BIO International conference next week, Healey's message is clear: Massachusetts is dedicated to fostering growth in the life sciences sector, ensuring that it remains a global hub for innovation and discovery. This investment is a testament to the state's commitment to creating jobs and supporting public health initiatives, reinforcing its position as a leader in the industry.